Skip to main content

Lindbrook Capital, LLC

SEC CIK
0001767045
Latest filing
May 5, 2025

MRSN holding history

Mersana Therapeutics, Inc. in every 13F filed by Lindbrook Capital, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MRSN overviewAll 13F holders of MRSNFull Q1 2025 holdings

Shares (Q1 2023)
0
Sold out in Q1 2023
Value
$0
% of portfolio
0.0%
Quarters held
3
Since Q1 2022
Holdings of MRSN by Lindbrook Capital, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20230$00.0%−445−100.0%Sold outHolders
Q4 2022445$2.61K<0.1%00.0%UnchangedHolders
Q3 2022445$3.00K<0.1%+445NewHolders
Q2 20220$00.0%−659−100.0%Sold outHolders
Q1 2022659$3.00K<0.1%+659NewHolders